Tovorafenib Impurity 12 | CAS 1935538-41-2 - Request Quote
Tovorafenib Impurity 12
| SZ CAT No: | SZ-T202015 |
| CAS No | 1935538-41-2 |
| Mol.F. | C6H5NO3S |
| Mol.Wt. | 171.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 12 is chemically 4-acetylthiazole-2-carboxylic acid. Tovorafenib Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1935538-41-2
Purchase 1935538-41-2
Order 1935538-41-2
Enquire 1935538-41-2
price of 1935538-41-2
1935538-41-2 Supplier
1935538-41-2 Manufacturer
1935538-41-2 Exporter
buy high quality Tovorafenib Impurity 12
Purchase Tovorafenib Impurity 12
Tovorafenib Impurity 12 suppliers
Tovorafenib Impurity 12 manufacturers
Tovorafenib Impurity 12 price
Order Tovorafenib Impurity 12
Enquire Tovorafenib Impurity 12
Tovorafenib Impurity 12 cost
Tovorafenib Impurity 12 Supplier
Tovorafenib Impurity 12 Distributor
Tovorafenib Impurity 12 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 12 for ANDA Filing
Tovorafenib Impurity 12 for Forced Degradation Studies
Tovorafenib Impurity 12 Identification Standards
Tovorafenib Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


